Inovio Pharmaceuticals, Inc.
Symbol: INO (NASDAQ)
2.63
▼ (-4.36%) -0.120
Company Description:
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Key Stats
- Today's Open: $2.74
- Today's High: $2.829
- Today's Low: $2.605
- Today's Volume: 1.23M
- Yesterday Close: $2.75
- Yesterday High: $2.9789
- Yesterday Low: $2.67
- Yesterday Volume: 2.39M
- Last Min Volume: 180
- Last Min High: $2.63
- Last Min Low: $2.63
- Last Min VWAP: $2.63
Company Profile
- Name: Inovio Pharmaceuticals, Inc.
- Website: https://www.inovio.com
- Listed Date: 1998-12-08
- Location: PLYMOUTH MEETING, PA
- Market Status: Active
- CIK Number: 0001055726
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $152.52M
- Round Lot: 100
- Outstanding Shares: 53.14M
- Asset Type: CS
RECENT FILINGS FOR INO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | 8-K | View |
| 2025-08-12 | 10-Q | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-07 | 8-K | View |
| 2025-07-03 | 424B5 | View |
| 2025-07-02 | 424B5 | View |
| 2025-07-01 | 4 | View |
| 2025-05-22 | 8-K | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-16 | 4 | View |
Latest News on INO